Key result
Prolonged PWAT is linked to cardiac compromise in pregnancy and shows potential for early screening.
Why the study?
Does pulse wave arrival time (PWAT) correlate with cardiac compromise in pregnant patients with a history of cardiac disease?
Observational (n=12)
Does pulse wave arrival time (PWAT) correlate with cardiac compromise in pregnant patients with a history of cardiac disease?
PWAT may serve as a useful noninvasive screening adjunct for detecting early cardiac dysfunction in pregnant women with known cardiac disease.
Pulse wave arrival time (PWAT) can be measured noninvasively by using the R-wave of the electrocardiogram and the peripheral pressure pulse. This report describes our preliminary observations in the use of this physiologic parameter to study a group of 12 pregnant patients with a history of cardiac disease. Their PWATs were compared to those recorded from normal, uncomplicated pregnant women, which were reported previously. All patients were clinically stable and without signs or symptoms of congestive heart failure. In seven patients the PWAT was either normal or shortened; the latter occurred in three patients whose pregnancies were complicated by hypertension. The PWAT was prolonged in all five cases with positive laboratory evidence of cardiac compromise. These data suggest that the PWAT may be a useful screening adjunct in the diagnosis and management of early cardiac dysfunction, but does not supplant the need for conventional cardiac evaluation methods.
No takes yet. Share an insight, caveat, or question.
Hon et al. (1993) conducted an observational in Pregnancy with a history of cardiac disease (n=12). Pulse wave arrival time (PWAT) measurement vs. Normal, uncomplicated pregnant women was evaluated on Pulse wave arrival time (PWAT).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: